Breast cancer in a cohort of human immunodeficiency virus (HIV) -infected women from Rio de Janeiro, Brazil: a cases series report and an incidence rate estimate

Andrade, A.Cristina.Vasconcelos.de.; Luz, P.Mendes.; Veloso, Véa.Gonçalves.; Cardoso, S.Wagner.; Moreira, R.Ismerio.; Grinsztejn, B.; Friedman, R.Khalili.

Brazilian Journal of Infectious Diseases An Official Publication of the Brazilian Society of Infectious Diseases 15(4): 387-393

2011


ISSN/ISBN: 1413-8670
PMID: 21861013
Document Number: 551870
Highly active antiretroviral therapy (HAART) has changed the morbidity pattern affecting HIV-infected individuals to include non-AIDS-defining cancers. We describe the breast cancer cases occurring in a cohort of 860 HIV-infected women followed in Rio de Janeiro, Brazil, and estimate the incidence rate of breast cancer for this population. Nine cases were identified; median age at diagnosis was 46 years. Median survival after breast cancer diagnosis was 12 months. Breast cancer diagnosis was made within 2 to 15 years of HIV-infection diagnosis. At breast cancer diagnosis, CD4 counts ranged from 135 to 782 cells/mm3; six women were receiving HAART. Histological analysis indicated infiltrating ductal carcinoma in all cases. The incidence rate of breast cancer was 133 cases per 100,000 persons-year. Patients from our case series were late diagnosed with breast cancer and thus suffered from worse prognosis. Strategies targeting earlier diagnosis and prompt initiation of treatment are needed.

Document emailed within 1 workday
Secure & encrypted payments